2,199 research outputs found
Pregnancy In Women Undergoing Hemodialysis: Case Series In A Southeast Brazilian Reference Center.
To describe maternal and neonatal outcomes in pregnant women undergoing hemodialysis in a referral center in Brazilian Southeast side. Retrospective and descriptive study, with chart review of all pregnancies undergoing hemodialysis that were followed-up at an outpatient clinic of high- risk prenatal care in Southeast Brazil. Among the 16 women identified, 2 were excluded due to follow-up loss. In 14 women described, hypertension was the most frequent cause of chronic renal failure (half of cases). The majority (71.4%) had performed hemodialysis treatment for more than one year and all of them underwent 5 to 6 hemodialysis sessions per week. Eleven participants had chronic hypertension, 1 of which was also diabetic, and 6 of them were smokers. Regarding pregnancy complications, 1 of the hypertensive women developed malignant hypertension (with fetal growth restriction and preterm delivery at 29 weeks), 2 had acute pulmonary edema and 2 had abruption placenta. The mode of delivery was cesarean section in 9 women (64.3%). All neonates had Apgar score at five minutes above 7. To improve perinatal and maternal outcomes of women undergoing hemodialysis, it is important to ensure multidisciplinary approach in referral center, strict control of serum urea, hemoglobin and maternal blood pressure, as well as close monitoring of fetal well-being and maternal morbidities. Another important strategy is suitable guidance for contraception in these women.375-
Chronically low nutrient concentrations in tree rings are linked to greater tree vulnerability to drought in nothofagus dombeyi
Forest dieback and mortality episodes triggered by droughts are receiving increasing atten-tion due to the projected increases in these extreme climate events. However, the role played by nutrient impairment in dieback is understudied, despite interactions among carbon-water balances and nutrition. Here, we followed a comparative analysis of long-term growth, intrinsic water-use efficiency (iWUE), oxygen isotopes (δ18O) and wood-nutrient composition patterns between living (L) and dead (D) trees of a Nothofagus dombeyi population, showing dieback in Argentina. The onset of the growth decline of D trees occurred ca. 40 years before death. These trees showed higher iWUE, pointing to higher drought stress. Their lower δ18O values, together with the uncoupling between δ18O and leaf-level processes, suggested a deeper source of water uptake for this vigor class. D trees showed a poorer nutritional status than L trees that likely amplified the dieback. This was supported by numerous positive associations of P-and K-concentrations in wood and related ratios with iWUE, δ18O and tree growth. Therefore, drought-related nutrient deterioration can significantly contribute to dieback and be an early warning signal of impending tree death.Fil: González de Andrés, Ester. Consejo Superior de Investigaciones CientÃficas. Instituto Pirenaico de EcologÃa; EspañaFil: Suarez, Maria Laura. Consejo Nacional de Investigaciones CientÃficas y Técnicas. Centro CientÃfico Tecnológico Conicet - Patagonia Norte. Instituto de Investigaciones en Biodiversidad y Medioambiente. Universidad Nacional del Comahue. Centro Regional Universidad Bariloche. Instituto de Investigaciones en Biodiversidad y Medioambiente; ArgentinaFil: Querejeta, José Ignacio. Consejo Superior de Investigaciones CientÃficas. Centro de EdafologÃa y BiologÃa Aplicada del Segura; EspañaFil: Camarero, J. Julio. Consejo Superior de Investigaciones CientÃficas. Instituto Pirenaico de EcologÃa; Españ
Geodynamic context for the deposition of coarse-grained deep-water axial channel systems in the Patagonian Andes
We present field and seismic evidence for the existence of Coniacian–Campanian syntectonic angular unconformities within basal foreland basin sequences of the Austral or Magallanes Basin, with implications for the understanding of deformation and sedimentation in the southern Patagonian Andes. The studied sequences belong to the mainly turbiditic Upper Cretaceous Cerro Toro Formation that includes a world-class example of conglomerate-filled deep-water channel bodies deposited in an axial foredeep depocentre. We present multiple evidence of syntectonic deposition showing that the present internal domain of the fold-thrust belt was an active Coniacian–Campanian wedge-top depozone where deposition of turbidites and conglomerate channels of Cerro Toro took place. Cretaceous synsedimentary deformation was dominated by positive inversion of Jurassic extensional structures that produced elongated axial submarine trenches separated by structural highs controlling the development and distribution of axial channels. The position of Coniacian-Campanian unconformities indicates a ca. 50–80 km advance of the orogenic front throughout the internal domain, implying that Late Cretaceous deformation was more significant in terms of widening the orogenic wedge than all subsequent Andean deformation stages. This south Patagonian orogenic event can be related to compressional stresses generated by the combination of both the collision of the western margin of Rocas Verdes Basin during its closure, and Atlantic ridge push forces due to its accelerated opening, during a global-scale plate reorganization event.Fil: Ghiglione, Matias. Consejo Nacional de Investigaciones CientÃficas y Técnicas. Oficina de Coordinación Administrativa Ciudad Universitaria. Instituto de Estudios Andinos "Don Pablo Groeber". Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales. Instituto de Estudios Andinos; ArgentinaFil: Likerman, Jeremias. Consejo Nacional de Investigaciones CientÃficas y Técnicas. Oficina de Coordinación Administrativa Ciudad Universitaria. Instituto de Estudios Andinos "Don Pablo Groeber". Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales. Instituto de Estudios Andinos; ArgentinaFil: Barberon, Vanesa. Consejo Nacional de Investigaciones CientÃficas y Técnicas. Oficina de Coordinación Administrativa Ciudad Universitaria. Instituto de Estudios Andinos "Don Pablo Groeber". Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales. Instituto de Estudios Andinos; ArgentinaFil: Giambiagi, Laura Beatriz. Consejo Nacional de Investigaciones CientÃficas y Técnicas. Centro CientÃfico Tecnológico Conicet - Mendoza. Instituto Argentino de NivologÃa, GlaciologÃa y Ciencias Ambientales. Provincia de Mendoza. Instituto Argentino de NivologÃa, GlaciologÃa y Ciencias Ambientales. Universidad Nacional de Cuyo. Instituto Argentino de NivologÃa, GlaciologÃa y Ciencias Ambientales; ArgentinaFil: Aguirre-Urreta, Maria Beatriz. Consejo Nacional de Investigaciones CientÃficas y Técnicas. Oficina de Coordinación Administrativa Ciudad Universitaria. Instituto de Estudios Andinos "Don Pablo Groeber". Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales. Instituto de Estudios Andinos; ArgentinaFil: Suarez, F.
Relevancia de la planeación tributaria para la gestión de procesos tributarios en las Pymes
The objective of the article consisted of reviewing the existing documentation on the application and implementation of tax planning, in order to establish whether it is feasible to conceive it as an improvement strategy in the management of tax processes to counteract problems of this type in the small and medium businesses. The method responds to a qualitative analysis of secondary information, built from bibliographic searches of articles and papers published in scientific databases. Multiple results were found that speak of the importance, the process for its applicability and benefits generated by tax planning, mostly dedicated to large companies, susceptible to transfer and adapt to smaller ones, given the scarcity of literature focused on this type of entities. In the discussion the possibilities and effects of tax planning in small and medium-sized companies are analyzed. As one of the main conclusions, tax planning is viewed as a strategy that generates benefits for the companies under analysisEl objetivo del articulo consistió en revisar la documentación existente sobre la aplicación e implementación de la planeación tributaria, con la finalidad de establecer si es factible concebirla como como una estrategia de mejora en la gestión de los procesos tributarios para contrarrestar problemáticas de este tipo en las pequeñas y medianas empresas. El método responde a un análisis cualitativo de información secundaria, construida a partir de búsquedas bibliográficas de artÃculos y trabajos publicados en bases de datos de carácter cientÃfico. Se encontraron múltiples resultados que hablan de la importancia, el proceso para su aplicabilidad y beneficios que genera la planeación tributaria., en su mayor parte dedicados a las grandes empresas, susceptible de trasladar y adaptar a las de menor tamaño, dada la escasez de literatura enfocada a este tipo de entidades. En la discusión se analizan las posibilidades y efectos de la planeación tributaria en las pequeñas y medianas empresas. Como una de las principales conclusiones se visualiza la planeación tributaria como una estrategia generadora de beneficios para las empresas objeto de análisi
Cost-minimization analysis favours intravenous ferric carboxymaltose over ferric sucrose for the ambulatory treatment of severe iron deficiency
Objective: Intravenous iron is widely used to treat iron deficiency in day-care units. Ferric carboxymaltose (FCM) allows administration of larger iron doses than iron sucrose (IS) in each infusion (1000 mg vs. 200 mg). As FCM reduces the number of infusions required but is more expensive, we performed a cost-minimization analysis to compare the cost impact of the two drugs. Materials and Methods: The number of infusions and the iron dose of 111 consecutive patients who received intravenous iron at a gastrointestinal diseases day-care unit from 8/2007 to 7/2008 were retrospectively obtained. Costs of intravenous iron drugs were obtained from the Spanish regulatory agencies. The accounting department of the Hospital determined hospital direct and indirect costs for outpatient iron infusion. Non-hospital direct costs were calculated on the basis of patient interviews. In the pharmacoeconomic model, base case mean costs per patient were calculated for administering 1000 mg of iron per infusion using FCM or 200 mg using IS. Sensitivity analysis and Monte Carlo simulation were performed. Results: Under baseline assumptions, the estimated cost of iron infusion per patient and year was €304 for IS and €274 for FCM, a difference of €30 in favour of FCM. Adding non-hospital direct costs to the model increased the difference to €67 (€354 for IS vs. €287 for FCM). A Monte Carlo simulation taking into account non-hospital direct costs favoured the use of FCM in 97% of simulations. Conclusion: In this pharmacoeconomic analysis, FCM infusion reduced the costs of iron infusion at a gastrointestinal day-care unit
Facilitating treatment engagement for early psychosis through peer-delivered decision support : Intervention development and protocol for pilot evaluation
Background: Emerging adults with early psychosis demonstrate high rates of service disengagement from critical early intervention services. Decision support interventions and peer support have both been shown to enhance service engagement but are understudied in this population. The purposes of this article are to describe the development of a novel peer-delivered decision coaching intervention for this population and to report plans for a pilot study designed to gather preliminary data about its feasibility, acceptability, and potential impact.
Methods: The intervention was developed based on formative qualitative data and in collaboration with a diverse team of researchers, key stakeholders, and expert consultants. The pilot trial will utilize a single-group (N = 20), pre-post, convergent mixed-methods design to explore whether and how the intervention addresses decision-making needs (the primary intervention target). The impact of the intervention on secondary outcomes (e.g., engagement in the program) will also be assessed. Additionally, through observation and feedback from the peer decision coach and study participants, we will evaluate the feasibility of research and intervention procedures, and the acceptability of information and support from the peer decision coach.
Discussion: The peer-delivered decision coaching intervention holds promise for assisting young people with making informed and values-consistent decisions about their care, and potentially enhancing service engagement within this traditionally difficult-to-engage population. If the intervention demonstrates feasibility and acceptability, and pilot data show its potential for improving treatment decision-making, our work will also lay the foundation for a new evidence base regarding roles for peer specialists on early intervention teams
Type A Insulin Resistance Syndrome- Novel insulin receptor gene mutation and familiar phenotypic variability
Type A Insulin Resistance Syndrome is due to heterozygous mutations in the insulin receptor (INSR) gene or its signaling pathway. We present a premenarcheal 14 year-old girl with normal BMI, severe hirsutism, acanthosis nigricans, clitoral hypertrophy, deep voice, enlarged polycystic ovaries, severe hyperinsulinemia and biochemical hyperandrogenism.We identifi ed a novel heterozygous missense variant in the tyrosine kinase domain of INSR(p.Leu1150Pro) and an heterozygous missense variant in SH2B adapter protein 1 involved in the insulin pathway (p.Ala663Val). Interestingly, the patients? mother and brother had the same INSR mutation although of a milder phenotype, reason why their IR went undiagnosed.The novel heterozygous p.Leu1150Pro mutation in the INSR gene appears to be the cause of the type A insulin resistance syndrome; the SH2B1 mutation, likely to synergistically affect the insulin pathway, may contribute to explain the more severe presentation of the phenotype in the patient and the phenotypic variability of the syndrome within this family.Fil: Freire, Analia. Consejo Nacional de Investigaciones CientÃficas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Centro de Investigaciones Endocrinológicas "Dr. César Bergada". Gobierno de la Ciudad de Buenos Aires. Centro de Investigaciones Endocrinológicas "Dr. César Bergada". Fundación de EndocrinologÃa Infantil. Centro de Investigaciones Endocrinológicas "Dr. César Bergada"; ArgentinaFil: Scaglia, Paula Alejandra. Consejo Nacional de Investigaciones CientÃficas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Centro de Investigaciones Endocrinológicas "Dr. César Bergada". Gobierno de la Ciudad de Buenos Aires. Centro de Investigaciones Endocrinológicas "Dr. César Bergada". Fundación de EndocrinologÃa Infantil. Centro de Investigaciones Endocrinológicas "Dr. César Bergada"; Argentina. Gobierno de la Ciudad de Buenos Aires. Hospital General de Niños "Ricardo Gutiérrez"; ArgentinaFil: Gryngarten, Mirta Graciela. Consejo Nacional de Investigaciones CientÃficas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Centro de Investigaciones Endocrinológicas "Dr. César Bergada". Gobierno de la Ciudad de Buenos Aires. Centro de Investigaciones Endocrinológicas "Dr. César Bergada". Fundación de EndocrinologÃa Infantil. Centro de Investigaciones Endocrinológicas "Dr. César Bergada"; ArgentinaFil: Gutiérrez, Mariana Lilián. Consejo Nacional de Investigaciones CientÃficas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Centro de Investigaciones Endocrinológicas "Dr. César Bergada". Gobierno de la Ciudad de Buenos Aires. Centro de Investigaciones Endocrinológicas "Dr. César Bergada". Fundación de EndocrinologÃa Infantil. Centro de Investigaciones Endocrinológicas "Dr. César Bergada"; ArgentinaFil: Arcari, Andrea Josefina. Consejo Nacional de Investigaciones CientÃficas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Centro de Investigaciones Endocrinológicas "Dr. César Bergada". Gobierno de la Ciudad de Buenos Aires. Centro de Investigaciones Endocrinológicas "Dr. César Bergada". Fundación de EndocrinologÃa Infantil. Centro de Investigaciones Endocrinológicas "Dr. César Bergada"; ArgentinaFil: Suarez, Laura. Consejo Nacional de Investigaciones CientÃficas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Centro de Investigaciones Endocrinológicas "Dr. César Bergada". Gobierno de la Ciudad de Buenos Aires. Centro de Investigaciones Endocrinológicas "Dr. César Bergada". Fundación de EndocrinologÃa Infantil. Centro de Investigaciones Endocrinológicas "Dr. César Bergada"; ArgentinaFil: Ballerini, Maria Gabriela. Consejo Nacional de Investigaciones CientÃficas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Centro de Investigaciones Endocrinológicas "Dr. César Bergada". Gobierno de la Ciudad de Buenos Aires. Centro de Investigaciones Endocrinológicas "Dr. César Bergada". Fundación de EndocrinologÃa Infantil. Centro de Investigaciones Endocrinológicas "Dr. César Bergada"; ArgentinaFil: Valinotto, Laura Elena. Consejo Nacional de Investigaciones CientÃficas y Técnicas; Argentina. Gobierno de la Ciudad de Buenos Aires. Hospital General de Niños "Ricardo Gutiérrez"; ArgentinaFil: Natale, Mónica Inés. Gobierno de la Ciudad de Buenos Aires. Hospital General de Niños "Ricardo Gutiérrez"; Argentina. Universidad de Buenos Aires; ArgentinaFil: Del Toro Camargo, Kenny. No especifÃca;Fil: Bergada, Cesar. Consejo Nacional de Investigaciones CientÃficas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Centro de Investigaciones Endocrinológicas "Dr. César Bergada". Gobierno de la Ciudad de Buenos Aires. Centro de Investigaciones Endocrinológicas "Dr. César Bergada". Fundación de EndocrinologÃa Infantil. Centro de Investigaciones Endocrinológicas "Dr. César Bergada"; ArgentinaFil: Rey, Rodolfo Alberto. Consejo Nacional de Investigaciones CientÃficas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Centro de Investigaciones Endocrinológicas "Dr. César Bergada". Gobierno de la Ciudad de Buenos Aires. Centro de Investigaciones Endocrinológicas "Dr. César Bergada". Fundación de EndocrinologÃa Infantil. Centro de Investigaciones Endocrinológicas "Dr. César Bergada"; Argentina. Gobierno de la Ciudad de Buenos Aires. Hospital General de Niños "Ricardo Gutiérrez"; ArgentinaFil: Ropelato, Maria Gabriela. Consejo Nacional de Investigaciones CientÃficas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Centro de Investigaciones Endocrinológicas "Dr. César Bergada". Gobierno de la Ciudad de Buenos Aires. Centro de Investigaciones Endocrinológicas "Dr. César Bergada". Fundación de EndocrinologÃa Infantil. Centro de Investigaciones Endocrinológicas "Dr. César Bergada"; Argentina. Gobierno de la Ciudad de Buenos Aires. Hospital General de Niños "Ricardo Gutiérrez"; Argentin
Recommended from our members
Individualized decision aid for diverse women with lupus nephritis (IDEA-WON): A randomized controlled trial.
BackgroundTreatment decision-making regarding immunosuppressive therapy is challenging for individuals with lupus. We assessed the effectiveness of a decision aid for immunosuppressive therapy in lupus nephritis.Methods and findingsIn a United States multicenter, open-label, randomized controlled trial (RCT), adult women with lupus nephritis, mostly from racial/ethnic minority backgrounds with low socioeconomic status (SES), seen in in- or outpatient settings, were randomized to an individualized, culturally tailored, computerized decision aid versus American College of Rheumatology (ACR) lupus pamphlet (1:1 ratio), using computer-generated randomization. We hypothesized that the co-primary outcomes of decisional conflict and informed choice regarding immunosuppressive medications would improve more in the decision aid group. Of 301 randomized women, 298 were analyzed; 47% were African-American, 26% Hispanic, and 15% white. Mean age (standard deviation [SD]) was 37 (12) years, 57% had annual income of <$40,000, and 36% had a high school education or less. Compared with the provision of the ACR lupus pamphlet (n = 147), participants randomized to the decision aid (n = 151) had (1) a clinically meaningful and statistically significant reduction in decisional conflict, 21.8 (standard error [SE], 2.5) versus 12.7 (SE, 2.0; p = 0.005) and (2) no difference in informed choice in the main analysis, 41% versus 31% (p = 0.08), but clinically meaningful and statistically significant difference in sensitivity analysis (net values for immunosuppressives positive [in favor] versus negative [against]), 50% versus 35% (p = 0.006). Unresolved decisional conflict was lower in the decision aid versus pamphlet groups, 22% versus 44% (p < 0.001). Significantly more patients in the decision aid versus pamphlet group rated information to be excellent for understanding lupus nephritis (49% versus 33%), risk factors (43% versus 27%), medication options (50% versus 33%; p ≤ 0.003 for all); and the ease of use of materials was higher in the decision aid versus pamphlet groups (51% versus 38%; p = 0.006). Key study limitations were the exclusion of men, short follow-up, and the lack of clinical outcomes, including medication adherence.ConclusionsAn individualized decision aid was more effective than usual care in reducing decisional conflict for choice of immunosuppressive medications in women with lupus nephritis.Trial registrationClinicaltrials.gov, NCT02319525
Neoadjuvant in situ vaccination with cowpea mosaic virus as a novel therapy against canine inflammatory mammary cancer
BackgroundInflammatory mammary cancer (IMC), the counterpart of human inflammatory breast cancer (IBC), is the deadliest form of canine mammary tumors. IMC patients lack specific therapy and have poor outcomes. This proof-of-principle preclinical study evaluated the efficacy, safety, and effect on survival of neoadjuvant intratumoral (in situ) empty cowpea mosaic virus (eCPMV) immunotherapy in companion dogs diagnosed with IMC.MethodsTen IMC-bearing dogs were enrolled in the study. Five dogs received medical therapy, and five received weekly neoadjuvant in situ eCPMV immunotherapy (0.2–0.4 mg per injection) and medical therapy after the second eCPMV injection. Efficacy was evaluated by reduction of tumor growth; safety by hematological and biochemistry changes in blood and plasma; and patient outcome by survival analysis. eCPMV-induced immune changes in blood cells were analyzed by flow cytometry; changes in the tumor microenvironment were evaluated by CD3 (T lymphocytes), CD20 (B lymphocytes), FoxP3 (Treg lymphocytes), myeloperoxidase (MPO; neutrophils), Ki-67 (proliferation index, PI; tumor cell proliferation), and Cleaved Caspase-3 (CC-3; apoptosis) immunohistochemistry.ResultsTwo neoadjuvant in situ eCPMV injections resulted in tumor shrinkage in all patients by day 14 without systemic adverse events. Although surgery for IMC is generally not an option, reduction in tumor size allowed surgery in two IMC patients. In peripheral blood, in situ eCPMV immunotherapy was associated with a significant decrease of Treg/CD8 ratio and changes in CD8Granzyme B T cells, which behave as a lagging predictive biomarker. In the TME, higher neutrophilic infiltration and MPO expression, lower tumor Ki-67 PI, increase in CD3 lymphocytes, decrease in FoxP3/CD3 ratio (p<0.04 for all comparisons), and no changes in CC-3 immunostainings were observed in post-treatment tumor tissues when compared with pretreatment tumor samples. eCPMV-treated IMC patients had a statistically significant (p=0.033) improved overall survival than patients treated with medical therapy.ConclusionsNeoadjuvant in situ eCPMV immunotherapy demonstrated anti-tumor efficacy and improved survival in IMC patients without systemic adverse effects. eCPMV-induced changes in immune cells point to neutrophils as a driver of immune response. Neoadjuvant in situ eCPMV immunotherapy could be a groundbreaking immunotherapy for canine IMC and a potential future immunotherapy for human IBC patients
Estudio de mercado para determinar las caracterÃsticas del segmento e interés de compra del mercado internacional en relación con el producto carne de Caracol enlatado
Carakool Ltda., será una empresa dedicada al cultivo y exportación de carne de caracol terrestre enlatado, mezclado con otros ingredientes, al mercado francés. La especie a cultivar, es la Hélix Aspersa, especie de mayor acogida en ParÃs.
Gracias a la importancia que tiene el indicador de calidad para la empresa, los cultivos estarán en constante cuidado, supervisando y controlando cada uno de los procesos productivos y las condiciones sanitarias necesarias para el desarrollo de la actividad, además del seguimiento de un zootecnista experto que no descuide la evolución del animal a nivel sanitario y de crecimiento.
Actualmente Carakool Ltda. se encuentra en la fase de introducción con cero participación en el mercado. El producto es innovador y entrará un mercado en el cual existe una gran demanda de esta carne, pero es necesario formular e implementar estrategias de mercadeo efectivas, para lograr dar a conocer, vender y posicionar el producto en l ciudad de ParÃs
- …